Introduction:
The pharmaceutical industry in Israel has been experiencing steady growth in recent years, with a focus on the production of generic medications. Montelukast, commonly known by the brand name Singulair, is a popular medication used to treat asthma and allergies. In this report, we will explore the top 10 Montelukast generic manufacturers in Israel, highlighting their production volume, market share, and overall performance in the industry.
Top 10 Montelukast (Singulair) Generic Manufacturers in Israel:
1. Teva Pharmaceutical Industries Ltd.
– Teva is the largest generic drug manufacturer in Israel and a global leader in the industry. They produce a significant volume of Montelukast generics, capturing a large market share both domestically and internationally.
2. Perrigo Company plc
– Perrigo is another major player in the Israeli pharmaceutical market, known for their high-quality generic medications, including Montelukast. They have a strong presence in the industry and continue to grow their market share.
3. Mylan N.V.
– Mylan is a well-established pharmaceutical company in Israel, producing a range of generic medications, including Montelukast. They have a solid reputation for quality and reliability in the industry.
4. Sandoz International GmbH
– Sandoz is a subsidiary of Novartis and a key player in the Israeli pharmaceutical market. They are known for their diverse portfolio of generic medications, including Montelukast, and have a strong presence in the industry.
5. Rafa Laboratories Ltd.
– Rafa Laboratories is a leading Israeli pharmaceutical company with a focus on generic medications. They produce a significant volume of Montelukast generics and have a loyal customer base in the country.
6. Taro Pharmaceutical Industries Ltd.
– Taro is a well-known Israeli pharmaceutical company with a global presence. They manufacture high-quality generic medications, including Montelukast, and have a strong market share in the industry.
7. Amdipharm Mercury Company Limited
– Amdipharm Mercury is a key player in the Israeli pharmaceutical market, known for their diverse portfolio of generic medications. They produce a range of Montelukast generics and have a growing market share in the industry.
8. Unipharm
– Unipharm is a leading Israeli pharmaceutical company with a focus on generic medications. They produce a significant volume of Montelukast generics and have a solid reputation for quality and reliability in the industry.
9. Kamada Ltd.
– Kamada is a well-established Israeli pharmaceutical company with a focus on specialty medications, including Montelukast. They have a niche market in the industry and continue to grow their presence in the country.
10. Macleods Pharmaceuticals Ltd.
– Macleods Pharmaceuticals is a global pharmaceutical company with a presence in Israel. They produce a range of generic medications, including Montelukast, and have a growing market share in the industry.
Insights:
The Israeli pharmaceutical industry has been witnessing a shift towards the production of generic medications, including Montelukast generics. With a focus on quality and affordability, Israeli manufacturers are well-positioned to meet the growing demand for generic medications both domestically and internationally. As the market continues to expand, we can expect to see further growth in production volume and market share for Montelukast generics in Israel. This trend is likely to continue in the coming years, making Israel a key player in the global pharmaceutical market.
Related Analysis: View Previous Industry Report
